Meilin Liao
- Oncology top 2%
- Lung Cancer Research Studies 11
- Colorectal Cancer Treatments and Studies 4
-
- Lung Cancer Treatments and Mutations 29
- Lung Cancer Diagnosis and Treatment 15
- Gastric Cancer Management and Outcomes 6
- Cancer Research top 5%
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Pathology and Forensic Medicine top 10%
-
- Multiple and Secondary Primary Cancers 4
-
- Angiogenesis and VEGF in Cancer 4
- Co-authors
- Maya GottfriedJoachim von PawelJosé BarruecoBirgit Gaschler‐MarkefskiAnders MellemgaardMaciej KrzakowskiIgor BondarenkoR. Kaiser
- Journals
- Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (1 paper)The Lancet Oncology (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Meilin Liao
44 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.6k
- Cancer Research 580
- Hepatology 87
- Pathology and Forensic Medicine 176
Countries citing papers authored by Meilin Liao
This map shows the geographic impact of Meilin Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilin Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilin Liao more than expected).
Fields of papers citing papers by Meilin Liao
This network shows the impact of papers produced by Meilin Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilin Liao. The network helps show where Meilin Liao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meilin Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 16 | |
| 2 | Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapybreakdown → | 2015 | 367 |
| 3 | 2015 | 40 | |
| 4 | Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trialbreakdown → | 2014 | 694 |
| 5 | 2013 | 22 | |
| 6 | 2012 | 5 | |
| 7 | 2012 | 27 | |
| 8 | 2012 | 38 | |
| 9 | 2010 | 17 | |
| 10 | 2009 | 38 | |
| 11 | 2009 | 36 | |
| 12 | 2009 | 19 | |
| 13 | 2008 | 5 | |
| 14 | 2007 | 1 | |
| 15 | Effect of thymosin α1 for advanced non-small-cell lung cancer in chemotherapy patients | 2005 | 1 |
| 16 | [The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer]. | 2002 | 3 |
| 17 | 2002 | 1 | |
| 18 | 2001 | 51 | |
| 19 | Homozygous deletion of p16 gene in non-small cell lung cancer | 1997 | 1 |
| 20 | 1996 | 23 |
About Meilin Liao
Meilin Liao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 45 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Research Studies (11 papers), Gastric Cancer Management and Outcomes (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Multiple and Secondary Primary Cancers (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Cancer Research (580 citations). Meilin Liao has collaborated with scholars based in China, United States and France. Frequent co-authors include Maya Gottfried, Joachim von Pawel, José Barrueco, Birgit Gaschler‐Markefski, Anders Mellemgaard, Maciej Krzakowski, Igor Bondarenko, R. Kaiser, Silvia Novello and Martin Reck. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.